BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krag A, Israelsen H, Ryberg BV, Andersen KK, Bendtsen F. Safety and efficacy of Profermin® to induce remission in ulcerative colitis. World J Gastroenterol 2012; 18(15): 1773-1780 [PMID: 22553401 DOI: 10.3748/wjg.v18.i15.1773]
URL: https://www.wjgnet.com/1007-9327/full/v18/i15/1773.htm
Number Citing Articles
1
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-AnalysisNutrients 2019; 11(2): 293 doi: 10.3390/nu11020293
2
Nasir Abbas, Mahrukh Shakil, Zeeshan Akhtar Rana, Sardar Basharat Ali, Ammad Ayub Awan, Saman Gul. A Systematic Review of the Role of Diet in Ulcerative ColitisCureus 2023;  doi: 10.7759/cureus.39350
3
Aleksander Krag, Pia Munkholm, Hans Israelsen, Bjørn von Ryberg, Klaus K. Andersen, Flemming Bendtsen. Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled TrialInflammatory Bowel Diseases 2013; 19(12): 2584 doi: 10.1097/01.MIB.0000437046.26036.db
4
Louis J. Cohen, Judy H. Cho, Dirk Gevers, Hiutung Chu. Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel DiseasesGastroenterology 2019; 156(8): 2174 doi: 10.1053/j.gastro.2019.03.017
5
Manuel Pabón-Carrasco, Lucia Ramirez-Baena, Samuel Vilar-Palomo, Aurora Castro-Méndez, Raúl Martos-García, Isabel Rodríguez-Gallego. Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical StudyNutrients 2020; 12(9): 2628 doi: 10.3390/nu12092628
6
Axel Dignass, James O. Lindsay, Andreas Sturm, Alastair Windsor, Jean-Frederic Colombel, Mathieu Allez, Gert D'Haens, André D'Hoore, Gerassimos Mantzaris, Gottfried Novacek, Tom Öresland, Walter Reinisch, Miquel Sans, Eduard Stange, Severine Vermeire, Simon Travis, Gert Van Assche. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current managementJournal of Crohn's and Colitis 2012; 6(10): 991 doi: 10.1016/j.crohns.2012.09.002
7
Wei-Feng Wang, Feng Zhou, Shan Xu, Yu-Liang Feng, Xiao-Yan Zhang, Qin Zhu, Qiao-Na He, Pei-Fen Zheng. Lactiplantibacillus plantarum attenuates 2,4,6-trinitrobenzenesulfonic acid-induced ulcerative colitis in rats by regulating the inflammatory response, T helper 17 immune response, and intestinal permeabilityBiologia 2022; 77(9): 2667 doi: 10.1007/s11756-022-01111-w
8
Giovanni Cammarota, Gianluca Ianiro, Rossella Cianci, Stefano Bibbò, Antonio Gasbarrini, Diego Currò. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapyPharmacology & Therapeutics 2015; 149: 191 doi: 10.1016/j.pharmthera.2014.12.006
9
Xiaoli Wang, Jingwen Zhao, Yuanhang Feng, Zelin Feng, Yulin Ye, Limin Liu, Guangbo Kang, Xiaocang Cao. Evolutionary Insights Into Microbiota Transplantation in Inflammatory Bowel DiseaseFrontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.916543
10
Cuilan Huang, Wujuan Hao, Xuyang Wang, Renmin Zhou, Qiong Lin. Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1211271
11
Olga Biskou, Susanna Walter, Hans Israelsen, Martin E. Winberg, Olga Bednarska, Åsa V. Keita. ReFerm®: a postbiotic fermented oat gruel composition is reducing mast cell degranulation in the colon of patients with irritable bowel syndromeFrontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1408623
12
Luiz C Di Stasi, Celso ARA Costa, Aline Witaicenis. Products for the treatment of inflammatory bowel disease: a patent review (2013 – 2014)Expert Opinion on Therapeutic Patents 2015; 25(6): 629 doi: 10.1517/13543776.2015.1041921
13
Olga Bednarska, Olga Biskou, Hans Israelsen, Martin E. Winberg, Susanna Walter, Åsa V. Keita. A postbiotic fermented oat gruel may have a beneficial effect on the colonic mucosal barrier in patients with irritable bowel syndromeFrontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1004084
14
Amal K. Mitra, Adetoun F. Asala, Shelia Malone, Malay Kanti Mridha. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical TrialsDiseases 2023; 11(4): 138 doi: 10.3390/diseases11040138
15
E. Arvidsson Nordström, C. Teixeira, C. Montelius, B. Jeppsson, N. Larsson. Lactiplantibacillus plantarum 299v (LP299V®): three decades of researchBeneficial Microbes 2021; 12(5): 441 doi: 10.3920/BM2020.0191
16
A. Dignass, J.O. Lindsay, A. Sturm, A. Windsor, J.-F. Colombel, M. Allez, G. d’Haens, A. d’Hoore, G. Mantzanaris, G. Novacek, T. Öresland, W. Reinisch, M. Sans, E. Stange, S. Vermeire, S. Travis, G. van Assche. Segundo consenso europeo basado en evidencia sobre el diagnóstico y manejo de la colitis ulcerosa crónica idiopática. Parte 2: tratamiento actual (versión española)Revista de Gastroenterología de México 2015; 80(1): 32 doi: 10.1016/j.rgmx.2014.10.007